Chronic Hepatitis C and comorbidities: real-world study to evaluate impact in outcomes after treatment with sofosbuvir-based regimens
F. Serejo(Hospital de Santa Maria), José Velosa(Hospital de Santa Maria), Ana Paula Tavares(Universidade Federal de São Paulo), Gonçalo Cruz(Hospitais da Universidade de Coimbra), Isabel Pedroto(Universidade do Porto), Lurdes Santos, Ana Horta(Hospital de Santo António), Rosário Serrão(Hospital de São João), Fernando Maltêz(Hospital Curry Cabral), Luís Veloso(Clinical Trial and Consulting), Rui Castro(Hospital de Santo António), Rui Tato Marinho(Villa Maria Hospital), Cristina Valente(Hospitais da Universidade de Coimbra), Guilherme Macedo(Hospital de São João), Sara Lino(Hospital Curry Cabral), António Sarmento(Fernando Pessoa University), Saraiva Cunha(Hospitais da Universidade de Coimbra), Vera Vicente(Clinical Trial and Consulting), Teresa Moreira(Hospital de Santo António), José Carlos Ferreira(Hospital do Rim e Hipertensão), Rodrigo Liberal(King's College - North Carolina), Maria José Manata(Hospital Curry Cabral), Filipe Calinas(Unidade Local de Saúde de São José)
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484